No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset

BACKGROUND: Spectral‐domain optical coherence tomography (OCT) may detect retinal changes as a biomarker in neurodegenerative diseases like manifest Huntington's disease (HD). We investigate macular retinal layer thicknesses in a premanifest HD (pre‐HD) cohort and healthy controls (HC). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmid, Rahel Dominique, Remlinger, Jana, Abegg, Mathias, Hoepner, Robert, Hoffmann, Rainer, Lukas, Carsten, Saft, Carsten, Salmen, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226796/
https://www.ncbi.nlm.nih.gov/pubmed/35511084
http://dx.doi.org/10.1002/brb3.2592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226796/
https://www.ncbi.nlm.nih.gov/pubmed/35511084
http://dx.doi.org/10.1002/brb3.2592

Ejemplares similares